Skip to main content
EQT Logo
Current Portfolio

SpliceBio

SpliceBio is a genetic medicines company developing next-generation gene therapies using its proprietary Protein Splicing platform. The technology, built on over two decades of research from the Muir Lab at Princeton University, enables efficient delivery of large genes previously inaccessible to conventional gene therapy.

Key Facts
Sector

Life Sciences

Country

Spain

Fund

LSP 7

Entry

2025

Website

SpliceBio

Responsible Partner

Daniela Begolo

Daniela Begolo

Managing Director

About

Do You Want to Know More?

We are eager to explore how we can achieve great things together.

SpliceBio | EQT Portfolio